About Factor Bioscience
Factor Bioscience is a company based in Cambridge (United States) founded in 2011 by Christopher Rohde. Factor Bioscience has raised $1 million across 4 funding rounds from investors including HHS and SBIR. Factor Bioscience operates in a competitive market with competitors including Senti Biosciences, Arbor Biotechnologies, Tenaya Therapeutics, Singleron and Bluebird Bio, among others.
- Headquarter Cambridge, United States
- Founders Christopher Rohde
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1 M (USD)
in 4 rounds
-
Latest Funding Round
$1 M (USD), Seed
Sep 15, 2025
-
Investors
HHS
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Factor Bioscience
Unlock access to complete
Unlock access to complete
Funding Insights of Factor Bioscience
Factor Bioscience has successfully raised a total of $1M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $1 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Factor Bioscience
Factor Bioscience has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and SBIR.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Federal innovation and scientific achievement services are provided.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Factor Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Factor Bioscience
Investment portfolio details for Factor Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Factor Bioscience
Detailed financials for Factor Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Factor Bioscience Comparisons
Peer comparison for Factor Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Factor Bioscience
Factor Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Arbor Biotechnologies, Tenaya Therapeutics, Singleron and Bluebird Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cell-based therapies for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Genomic technologies and drug discovery platforms are provided.
|
|
| Locked | Locked | Locked |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| Locked | Locked | Locked |
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis
|
|
| Locked | Locked | Locked |
Gene therapies for severe genetic and rare diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for chronic diseases by targeting mast cells and stem cells
|
Detailed competitors of Factor Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Factor Bioscience
Complete news archive for Factor Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Factor Bioscience
Factor Bioscience was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Factor Bioscience is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Factor Bioscience is a funded company, having raised a total of $1M across 4 funding rounds to date.
Factor Bioscience was founded in 2011 in Cambridge, United States, within the biotechnology sector. Gene-editing and cell-reprogramming technologies are utilized to generate clonal lines of pluripotent stem cells and advance regenerative cell therapies. Disease-focused approaches are applied to address cancer, genetic disorders, infectious conditions, and degenerative diseases through targeted treatments. Operations emphasize innovation in genomic applications for health improvement.
Factor Bioscience's top competitors include Senti Biosciences, Arbor Biotechnologies and Tenaya Therapeutics.